AgomAb Therapeutics NV

AGMBNASDAQ
$15.00
0.503.45%
At close: Aug 7, 5:00 PM EST
$15.26
0.765.24%
Pre-Market: 4:13 AM EST
Earnings: H1 2026 Earnings were released on Thu Aug 6th, after the market close

AgomAb Therapeutics Market Sentiment

Market sentiment signals for AgomAb Therapeutics (AGMB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus Buy
Short Interest 3.0% short float
Options Flow N/A
Insider Activity N/A

Analyst Consensus

Buy

5 analysts

Options Flow (P/C)

Avg Consensus PT

$33

+116.3%

Highest Price Target

$36

+135.9%

Leerink Partners

Lowest Price Target

$28

+83.5%

Morgan Stanley

Short Interest

3.0%

Insider Activity (30d)

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Jul 23, 2026B. Riley Securities
William Woods
+122.8%$34InitiateBuy
Jun 22, 2026HC Wainwright & Co.
Patrick R. Trucchio
+129.4%$35InitiateBuy